DNA based kits seem to be more expensive by an order of magnitude. They’re slightly more accurate - but also longer to process.
The other major factor in the mix is integration. Colostat will fit into existing pathology architecture tomorrow. Other systems not so much - requiring bespoke processing hardware to be bought and taught to staff.
- Forums
- ASX - By Stock
- RHY
- Ann: MST Access Financial Diagnostics Presentation
Ann: MST Access Financial Diagnostics Presentation, page-48
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.85M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 10.0¢ | $5K | 50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 55913 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 18707 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 55913 | 0.100 |
2 | 37341 | 0.099 |
1 | 10000 | 0.098 |
1 | 30927 | 0.097 |
3 | 185500 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 18707 | 1 |
0.110 | 96084 | 2 |
0.115 | 26554 | 2 |
0.130 | 4000 | 1 |
0.140 | 11100 | 1 |
Last trade - 10.08am 05/11/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |